谷歌浏览器插件
订阅小程序
在清言上使用

RESULTS FROM A PHASE 2A, OPEN- LABEL STUDY TO EVALUATE THE SAFETY AND EFFICACY OF NOVEL COMBINATION THERAPIES CONTAINING VIR-2218, SELGANTOLIMOD, AND NIVOLUMAB FOR THE TREATMENT OF CHRONIC HEPATITIS B

HEPATOLOGY(2024)

引用 0|浏览0
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要